In our data, 61.8% of the pediatric ischemic stroke with COVID-19 cases have concomitant elevation of inflammatory markers (i.e., ESR, CRP, IL-6, fibrinogen, ferritin, procalcitonin and D-dimer). The gene discussed is ESR1; the disease is COVID-19.